Evidence map›Paper›PMID 31829768›Full record

ReviewTranscription2020

Enhancers as regulators of antigen receptor loci three-dimensional chromatin structure.

E Mauricio Barajas-Mora, Ann J Feeney

Abstract readReview
In one paragraph

Review in Transcription, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

E Mauricio Barajas-MoraDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Ann J FeeneyDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.

Funding

Locus contraction at the Ig kappa locusR56AI119092 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI FEENEY, ANN J · 2016 to 2016
$481k
NIAID NIH HHS R56 AI119092
6 · The paper itself

Abstract

Enhancers are defined as regulatory elements that control transcription in a cell-type and developmental stage-specific manner. They achieve this by physically interacting with their cognate gene promoters. Significantly, these interactions can occur through long genomic distances since enhancers may not be near their cognate promoters. The optimal coordination of enhancer-regulated transcription is essential for the function and identity of the cell. Although great efforts to fully understand the principles of this type of regulation are ongoing, other potential functions of the long-range chromatin interactions (LRCIs) involving enhancers are largely unexplored. We recently uncovered a new role for enhancer elements in determining the three-dimensional (3D) structure of the immunoglobulin kappa (Igκ) light chain receptor locus suggesting a structural function for these DNA elements. This enhancer-mediated locus configuration shapes the resulting Igκ repertoire. We also propose a role for enhancers as critical components of sub-topologically associating domain (subTAD) formation and nuclear spatial localization.

Indexed as

AnimalsChromatinHumansProtein ConformationReceptors, AntigenChromatinReceptors, Antigen3D structureantibody repertoireantigen receptor locichromatin conformation captureEnhancerIgκlong-range chromatin interactionsloop extrusionnuclear topologysubTADV(D)J recombination

Identifiers

PMID31829768
PMCPMC7053977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.